---
figid: PMC10380707__ijms-24-11478-g002
pmcid: PMC10380707
image_filename: ijms-24-11478-g002.jpg
figure_link: /pmc/articles/PMC10380707/figure/ijms-24-11478-f002/
number: Figure 2
figure_title: ''
caption: 'Dopamine and bilirubin metabolism, biological effects, and shared signaling
  pathway. (a) Cartoon showing dopamine (left) and bilirubin (right) metabolism. (b)
  Cartoon resuming the principal effectors of DA dysregulation in neuropsychiatric
  and neurodegenerative conditions described in this paper (left), and the potential
  beneficial effects of YPS based both on clinic and experimental information (right),
  and the main signaling pathway shared between the neurologic conditions and YPs
  (middle). ↑: increase; ↓: decrease; TH: tyrosine hydroxylase; L-DOPA: L-dihydroxyphenylalanine;
  DA: dopamine; MAO: monoamine oxidase; DOPAL: 3,4-dihydroxyphenylacetaldehyde; ALDH:
  aldehyde dehydrogenases; DOPAC: 3,4-dihydroxyphenylacetic acid; COMT: catechol-o-methyltransferase;
  HVA: homovanilic acid. Heme: hemoglobin; HMOX: heme oxygenase; BV: biliverdin; BLVR:
  biliverdin reductase; UCB: unconjugated bilirubin («bilirubin»); UGT1a1: uridine-glucuronosyl
  transferase 1a1; CB: conjugated bilirubin; ROS: reactive oxygen species; noOS: unreactive
  oxygen species; PD: Parkinson’s disease; NOS: nitrogen reactive species; COX2: cyclooxygenase
  2; CXCL12: C-X-C motif chemokine ligand 12; TNF: tumor necrosis factor; IL: interleukin;
  TLR4: Toll-Like Receptor 4; MAPK: mitogen-activated protein kinase; NFkβ: Nuclear
  factor NF-kappa-B; RE: responsive elements; TNF-R1: tumor necrosis factor receptor
  1; ADHD: attention deficit hyperactivity disorder; ASD: autism spectrum disorder;
  IFN: interferon; Dp: depression; PPAR: peroxisome proliferator-activated receptors;
  Add: addiction; DR5: dopamine receptor 5; MS: multiple sclerosis; Sch: schizophrenia;
  EAE: experimental autoimmune encephalomyelitis (model of MS. multiple sclerosis).'
article_title: Inflammation, Dopaminergic Brain and Bilirubin.
citation: Sri Jayanti, et al. Int J Mol Sci. 2023 Jul;24(14):11478.
year: '2023'

doi: 10.3390/ijms241411478
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI

keywords:
- addiction
- cognition
- depression
- schizophrenia
- Parkinson’s disease
- attention deficit hyperactivity disorder
- tumor necrosis factor
- PPARs
- NFkβ
- MAPKs

---
